‘Watershed’ coronavirus vaccine looks to be 90% effective in phase 3 trial of 43,500 people
The US Food and Drug Administration (FDA) set a minimum effectiveness bar for COVID-19 vaccines at 50% for drugs seeking approval. This is the first COVID-19 candidate vaccine to produce data exceeding that mark.